- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04874090
The Effectiveness of Acupuncture Therapy on Pain in Parkinson's Disease
Investigation of the Effectiveness of Dry Needle Treatment Applied to Acupuncture Points in Parkinson's Disease on Pain
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Parkinson's Disease (PD) is a chronic, progressive, degenerative movement disorder that is characterized by motor and nonmotor symptoms and its incidence increases with age. It is the second most common neurodegenerative disease after Alzheimer's.Bradykinesia, which is characterized by rigidity, resting tremor, postural instability, gait disturbance and progressive decrease in the speed and amplitude of repetitive movements throughout the course of the disease, are the main cardinal motor findings.Sensory dysfunction such as non-motor findings in PD, disruption in the sleep-wake cycle, neuropsychiatric findings such as dementia, confusion, hallucinations, delirium, depression, gastrointestinal dysfunction, autonomic nervous system disorders such as bladder dysfunction, orthostatic hypotension, and pain perception may develop.Although dopaminergic therapies in PD are the gold standard in the treatment of disorders such as bradykinesia, rigidity and tremor, adequate response cannot be obtained in the treatment of non-motor symptoms. For this reason, rehabilitative applications, especially pain symptom, and complementary medicine methods are very important.It has been reported that 40-90% of patients have pain symptoms in PD. Pain can be the result of motor fluctuations, dystonic muscle contractions, deep visceral pain, and musculoskeletal pain.
Acupuncture and dry needling therapy have been used clinically for a long time as pain relievers such as migraine pain, low back pain, chronic pain and cancer pain. On the other hand, there are very limited and very limited number of studies on the efficacy of dry needle therapy applied to acupuncture points in pain control in PD.In this study, our aim is to investigate the effectiveness of dry needling treatment applied to acupuncture points in neck pain due to PH on musculoskeletal pains.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Bolu, Turkey, 14030
- Elif Yakşi
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Being Parkinson's Disease
- Age 45-75
- Have a pain due to Parkinson's Disease
Exclusion Criteria:
- Presence of advanced dementia or mental disability
- Pain due to ınflammatory conditions
- Using anticoagulant therapy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Interventional group
Investigator will apply the acupuncture treatment to the first group to the neck area.
BL-15, BL-18, BL-23, BL-25, KB-4, Du-20, GB-20, CV-14, KB-10, Ex-26, Yin Tang, Ah-shi points will be used.
0.25x25 mm, sterile, steel, disposable, acupuncture needle will be used for acupuncture points and painful trigger points.
The treatment will be applied twice a week, on average 10 sessions.
Dry needling treatment will be applied to the patients by a certified physician.
All patient will be performed the neck exercises program.
|
Investigator will apply the acupuncture treatment to the first group to the neck area.
BL-15, BL-18, BL-23, BL-25, KB-4, Du-20, GB-20, CV-14, KB-10, Ex-26, Yin Tang, Ah-shi points will be used.
0.25x25 mm, sterile, steel, disposable, acupuncture needle will be used for acupuncture points and painful trigger points.
The treatment will be applied twice a week, on average 10 sessions.
Dry needling treatment will be applied to the patients by a certified physician.
All patient will be performed the neck exercises program
Patient will perform neck exercises
|
Other: Exercises group
Patients will perform only neck exercises.
|
Patient will perform neck exercises
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Visuel Analog Scale
Time Frame: Baseline
|
This scale consists of a 100 mm horizontal line and is marked from 0 to 10.
In our study, patients were told that the "0" point was not pain at all, and the "10" point showed unbearable pain, and patients were asked to mark their pain intensity by considering their pain at rest.
|
Baseline
|
Visuel Analog Scale
Time Frame: 6 weeks
|
This scale consists of a 100 mm horizontal line and is marked from 0 to 10.
In our study, patients were told that the "0" point was not pain at all, and the "10" point showed unbearable pain, and patients were asked to mark their pain intensity by considering their pain at rest.
|
6 weeks
|
Neck Disability Index
Time Frame: Baseline
|
This index consists of 10 questions and is used to evaluate how and to what extent the neck pain affects the daily life activities of the patient.
Neck disability index includes the severity of pain, self-care, load-lifting, reading, headache, concentration, driving, sleep, and social activity parameters.
The patients are asked to mark the most appropriate for them from the 6 options given for each parameter.
Each title is scored from 0 "(no disability) to 5" (complete disability).
The total score is between 0 (no disability) and 50 (total disability).
After the total score is obtained, the value calculated according to the formulation is concluded as % insufficiency.
High scores indicate high disability, and low scores indicate a low disability level.
|
Baseline
|
Neck Disability Index
Time Frame: 6 weeks
|
This index consists of 10 questions and is used to evaluate how and to what extent the neck pain affects the daily life activities of the patient.
Neck disability index includes the severity of pain, self-care, load-lifting, reading, headache, concentration, driving, sleep, and social activity parameters.
The patients are asked to mark the most appropriate for them from the 6 options given for each parameter.
Each title is scored from 0 "(no disability) to 5" (complete disability).
The total score is between 0 (no disability) and 50 (total disability).
After the total score is obtained, the value calculated according to the formulation is concluded as % insufficiency.
High scores indicate high disability, and low scores indicate a low disability level.
|
6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Health Assesment Quality
Time Frame: Baseline
|
This questionnaire consists of eight questions designed to assess the effects of individuals' health status on daily living.
Day-to-day activities such as dressing, hygiene, eating, and walking are assessed, and high scores indicate poor health status.
|
Baseline
|
Health Assesment Quality
Time Frame: 6 weeks
|
This questionnaire consists of eight questions designed to assess the effects of individuals' health status on daily living.
Day-to-day activities such as dressing, hygiene, eating, and walking are assessed, and high scores indicate poor health status.
|
6 weeks
|
MDS-Unified Parkinson's Disease Rating Scale
Time Frame: Baseline
|
This is an extensive scale employed for the clinical evaluation of severity of PD.
It consists of four sections including non-motor findings, motor problems, motor findings, and treatment complications.
Fourteen motor findings (0 - no finding, or normal, 4- severe finding) in the second section of the scale and comprising the motor problems part.
|
Baseline
|
MDS-Unified Parkinson's Disease Rating Scale
Time Frame: 6 weeks
|
This is an extensive scale employed for the clinical evaluation of severity of PD.
It consists of four sections including non-motor findings, motor problems, motor findings, and treatment complications.
Fourteen motor findings (0 - no finding, or normal, 4- severe finding) in the second section of the scale and comprising the motor problems part.
|
6 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AIBU-FTR-EY-04
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedParkinson Disease 6, Early-Onset | Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human | Parkinson Disease Autosomal Recessive, Early Onset | Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1United States
-
ProgenaBiomeRecruitingParkinson Disease | Parkinsons Disease With Dementia | Parkinson-Dementia Syndrome | Parkinson Disease 2 | Parkinson Disease 3 | Parkinson Disease 4United States
-
King's College LondonGlaxoSmithKlineCompletedParkinson Disease | Idiopathic Parkinson Disease | Parkinson Disease, PARK8United Kingdom
-
Ohio State UniversityCompletedParkinson's Disease | Parkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease | Parkinson Disease, Idiopathic | Parkinson's Disease, IdiopathicUnited States
-
National Yang Ming UniversityUnknownEarly Onset Parkinson Disease | Early Stage Parkinson Disease
-
Michele Tagliati, MDRecruitingREM Sleep Behavior Disorder | Symptomatic Parkinson Disease | Pre-motor Parkinson DiseaseUnited States
-
Cedars-Sinai Medical CenterEnrolling by invitationREM Sleep Behavior Disorder | Symptomatic Parkinson Disease | Pre-motor Parkinson DiseaseUnited States
-
Mahatma Gandhi Institute of Medical SciencesCompletedStroke, Parkinson' s Disease, Neurological Impairments, Tele-rehabilitationIndia
-
Merck Sharp & Dohme LLCCompletedParkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease
-
University of DeustoCompletedPARKINSON DISEASE (Disorder)Spain
Clinical Trials on Acupuncture
-
Federal University of São PauloCompleted
-
University of ZurichCharite University, Berlin, Germany; First Teaching Hospital of Tianjin University...CompletedExperimental Dental PainSwitzerland
-
University of SkövdeCompleted
-
National Research Centre of Complementary and Alternative...Norwegian Acupuncture CollegeUnknown
-
Chengdu University of Traditional Chinese MedicineChongqing Medical University; Hunan University of Traditional Chinese MedicineCompletedFunctional Dyspepsia | Postprandial Distress SyndromeChina
-
University of MichiganMassachusetts General Hospital; National Center for Complementary and Integrative...Completed
-
Chang Gung Memorial HospitalRecruitingIntracranial HemorrhagesTaiwan
-
University Medicine GreifswaldRecruitingGagging During Transesophageal EchocardiographyGermany
-
Huazhong University of Science and TechnologyThe University of Hong Kong; Heilongjiang University of Chinese Medicine; Hubei...CompletedPolycystic Ovary SyndromeChina
-
China Medical University HospitalNot yet recruiting